FARMINGTON HILLS, Mich., Aug. 21, 2019 /PRNewswire-PRWeb/ -- E.M.M.A. International Consulting Group, Inc. (EMMA International) a global leader in quality, regulatory, and compliance services for the Biotechnology, Pharmaceuticals, and Medical Device industries, welcomes Dr. Carrie Kuehn as Director of Regulatory Affairs. In this position, Dr. Kuehn will be responsible for global regulatory strategic development, oversight of regulatory submissions, and interactions with US and international governmental health authorities. The appointment of Dr. Kuehn to lead the company's regulatory affairs team reflects EMMA International's commitment to serve its clients in navigating the complexities of the U.S. Food and Drug Administration (FDA) approval process.
Dr. Kuehn is an experienced FDA Regulatory Affairs professional with a diverse background and over 20 years of experience in epidemiology, medicine, FDA regulatory affairs and patient-focused policy. In practice, Dr. Kuehn has applied her skills and expertise to address the needs of medical device companies in regulatory affairs. Dr. Kuehn excels at taking complex, multidisciplinary problems and synthesizing them into a cohesive strategy. An accomplished researcher, Dr. Kuehn has published in the areas of public health, regulatory affairs, and patient engagement policy. As part-time faculty at Northeastern University's Regulatory Affairs Graduate program, Dr. Kuehn helps to prepare the next generation of patient-focused regulatory professionals. With a patient-focused work ethic, Dr. Kuehn applies her adaptable skill set to address the complex issues of her clients to improve patient lives around the world.
"I am pleased to welcome Dr. Kuehn to EMMA International's management team," said Dr. Carmine Jabri, EMMA International's President. "Dr. Kuehn brings a wealth of industry knowledge. Dr. Kuehn has both the technical expertise and the business development acumen that will enable our firm to further our current collaborative relationships, develop new business opportunities, and expand the Regulatory Affairs growth for the Company."
Dr. Kuehn earned her Doctorate in Law and Policy from Northeastern University and holds a Master's degree in Public Health and a Master's degree in Biocultural (Physical) Anthropology from the University of Washington. Dr. Kuehn is RAC certified by the Regulatory Affairs Professionals Society.
SOURCE EMMA International
Advertisement
Dr. Kuehn is an experienced FDA Regulatory Affairs professional with a diverse background and over 20 years of experience in epidemiology, medicine, FDA regulatory affairs and patient-focused policy. In practice, Dr. Kuehn has applied her skills and expertise to address the needs of medical device companies in regulatory affairs. Dr. Kuehn excels at taking complex, multidisciplinary problems and synthesizing them into a cohesive strategy. An accomplished researcher, Dr. Kuehn has published in the areas of public health, regulatory affairs, and patient engagement policy. As part-time faculty at Northeastern University's Regulatory Affairs Graduate program, Dr. Kuehn helps to prepare the next generation of patient-focused regulatory professionals. With a patient-focused work ethic, Dr. Kuehn applies her adaptable skill set to address the complex issues of her clients to improve patient lives around the world.
Advertisement
"I am pleased to welcome Dr. Kuehn to EMMA International's management team," said Dr. Carmine Jabri, EMMA International's President. "Dr. Kuehn brings a wealth of industry knowledge. Dr. Kuehn has both the technical expertise and the business development acumen that will enable our firm to further our current collaborative relationships, develop new business opportunities, and expand the Regulatory Affairs growth for the Company."
Dr. Kuehn earned her Doctorate in Law and Policy from Northeastern University and holds a Master's degree in Public Health and a Master's degree in Biocultural (Physical) Anthropology from the University of Washington. Dr. Kuehn is RAC certified by the Regulatory Affairs Professionals Society.
SOURCE EMMA International
